Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0E6AP
|
||||
| Former ID |
DIB006011
|
||||
| Drug Name |
STX
|
||||
| Synonyms |
Selective estrogen receptor modulator (menopause-associated symptoms), Oregon Health & Science University
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Estrogen deficiency [ICD10:E28.39] | Investigative | [543898] | ||
| Company |
Oregon Health Sciences University
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C9H15N3O2
|
||||
| Canonical SMILES |
CC(C)(C)C1=NN=C(O1)C(=O)CNC
|
||||
| InChI |
1S/C9H15N3O2/c1-9(2,3)8-12-11-7(14-8)6(13)5-10-4/h10H,5H2,1-4H3
|
||||
| InChIKey |
CLBJJWUUSJAAPJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Modulator | [543898] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.